Valuation
- Market cap
- 3,347,000
- Revenue TTM
- $13,790,000
- Net income TTM
- $-960,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -6.96%
- Debt to equity
- 0.01
Trading
- Volume
- 45,100
- Avg volume
- 525,370
- Day's range
- $0.01 – $0.01
- Shares out
- 235,694,000
- Stochastic %K
- 59%
- Beta
- 0.43
- Analysts
- Strong Buy
- Price target
- $0.05
Company profile
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, selec...
Show more
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 866 290 2157
- Website
- https://www.cvsciences.com
- Address
- 9530 Padgett Street, Suite 107, San Diego, United States
Latest news
No headlines yet.
